Literature DB >> 16267514

Wartime tactic doubles power of scarce bird-flu drug.

Declan Butler.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16267514     DOI： 10.1038/438006a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression.

Authors:  Mohamed A Kamal; Ronald Gieschke; Annabelle Lemenuel-Diot; Catherine A A Beauchemin; Patrick F Smith; Craig R Rayner
Journal:  Antimicrob Agents Chemother       Date:  2015-06-22       Impact factor: 5.191

2.  Blockade of Organic Anion Transport in Humans After Treatment With the Drug Probenecid Leads to Major Metabolic Alterations in Plasma and Urine.

Authors:  Jeffry C Granados; Vibha Bhatnagar; Sanjay K Nigam
Journal:  Clin Pharmacol Ther       Date:  2022-05-22       Impact factor: 6.903

3.  Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine model.

Authors:  Sheryl E Koch; Michael Tranter; Nathan Robbins; Kristin Luther; Umesh Singh; Min Jiang; Xiaoping Ren; Trisha Tee; Leah Smith; Priyanka Varma; W Keith Jones; Jack Rubinstein
Journal:  J Cardiovasc Pharmacol Ther       Date:  2012-12-14       Impact factor: 2.457

Review 4.  Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations.

Authors:  Brian E Davies
Journal:  J Antimicrob Chemother       Date:  2010-04       Impact factor: 5.790

5.  Targeting organic anion transporter 3 with probenecid as a novel anti-influenza a virus strategy.

Authors:  Olivia Perwitasari; Xiuzhen Yan; Scott Johnson; Caleb White; Paula Brooks; S Mark Tompkins; Ralph A Tripp
Journal:  Antimicrob Agents Chemother       Date:  2012-11-05       Impact factor: 5.191

6.  Probenecid: novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation.

Authors:  Sheryl E Koch; Xiaoqian Gao; Lauren Haar; Min Jiang; Valerie M Lasko; Nathan Robbins; Wenfeng Cai; Cole Brokamp; Priyanka Varma; Michael Tranter; Yong Liu; Xiaoping Ren; John N Lorenz; Hong-Sheng Wang; W Keith Jones; Jack Rubinstein
Journal:  J Mol Cell Cardiol       Date:  2012-04-27       Impact factor: 5.000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.